glp 1 agonist vs sglt2 inhibitor Frontiers SGLT2 Inhibitors and GLP-1 Receptor
Description
In summary, Arakawa M, et al
We acknowledge that the inclusion of only four studies in the quantitative synthesis limits the statistical power of our subgroup analyses, particularly when examining outcomes over multiple time points (3, 6, 12, and 24 months)
Whats Next If this message resonates, if youve realized your weight struggle runs deeper than dietsits time to heal whats really underneath
Understanding why requires looking at the underlying physiology
Rights and permissions About this article Cite this article Meier, J.J., Nauck, M.A
Diabetes 58 , 461-P (2009)
